August 13, 2025 · Form 4 insider transaction
Malley Thomas sold 50,129 shares of Kiniksa Pharmaceuticals Ltd. at $33.32 per share, a transaction worth $1.67M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.1301 and $33.50. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.